Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Genome-wide Screening Reveals That Mir-195 Targets the TNF-α/NF-κB Pathway by Down-Regulating IκB Kinase Alpha and TAB3 in Hepatocellular Carcinoma.

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

NF-κB Signaling Relieves Negative Regulation by Mir-194 in Hepatocellular Carcinoma by Suppressing the Transcription Factor HNF-1α.

Mir‐1287 Suppresses the Proliferation, Invasion, and Migration in Hepatocellular Carcinoma by Targeting PIK3R3

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Mir-146A is Directly Regulated by STAT3 in Human Hepatocellular Carcinoma Cells and Involved in Anti-Tumor Immune Suppression.

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

Mir-301a-5p/Scin Promotes Gastric Cancer Progression Via Regulating Stat3 And Nf-Kappa B Signaling

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling

Genome-Wide Screening Identified That Mir-134 Acts As A Metastasis Suppressor by Targeting Integrin Beta 1 in Hepatocellular Carcinoma

Upregulation Of Mir-23a Similar To 27a Similar To 24 Decreases Transforming Growth Factor-Beta-Induced Tumor-Suppressive Activities In Human Hepatocellular Carcinoma Cells

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Downregulation of Mir-199A-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism Via GEO, TCGA Database and in Silico Analyses

Mir-19A Promotes Colitis-Associated Colorectal Cancer by Regulating Tumor Necrosis Factor Alpha-Induced Protein 3-Nf-κb Feedback Loops

DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma

Correction: Mir-135B Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.

MicroRNA‐127‐5p Targets the Biliverdin Reductase B/nuclear Factor‐κb Pathway to Suppress Cell Growth in Hepatocellular Carcinoma Cells

CTNNA3 is a Tumor Suppressor in Hepatocellular Carcinomas and is Inhibited by Mir-425